SIRT6 is a pivotal regulator of lipid metabolism. It is also closely connected to cardiovascular diseases, which are the main cause of death in diabetic patients. We observed a decrease in the expression of SIRT6 and key autophagy effectors (ATG5, LC3B, and LAMP1) in ox-LDL-induced foam cells, a special form of lipid-laden macrophages. In these cells, SIRT6 WT but not SIRT6 H133Y overexpression markedly reduced foam cell formation, as shown by Oil Red O staining, while inducing autophagy flux, as determined by both mRFP-GFP-LC3 labeling and transmission electron microscopy. Silencing the key autophagy initiation gene ATG5, reversed the autophagy-promoting effect of SIRT6 in ox-LDL-treated THP1 cells, as evidenced by an increase in foam cells. Cholesterol efflux assays indicated that SIRT6 overexpression in foam cells promoted cholesterol efflux, increased the levels of ABCA1 and ABCG1, and reduced miR-33 levels. By transfecting miR-33 into cells overexpressing SIRT6, we observed that reduced foam cell formation and autophagy flux induction were largely reversed. These data imply that SIRT6 plays an essential role in protecting against atherosclerosis by reducing foam cell formation through an autophagy-dependent pathway.
Introduction
Atherosclerosis (AS) has emerged as the leading cause of morbidity and mortality in diabetic patients worldwide [1] . Macrophage foam cell formation is a typical pathological change associated with early AS. It is characterized by an imbalance of cholesterol influx and efflux, and the accumulation of cholesterol esters (CE) within cytoplasmic lipid droplets (LDs) [2] . The pathogenesis of AS is complicated by the numerous factors that participate in initiating this process, such as dyslipidemia, local low-grade inflammation, and endothelial injury [3] [4] [5] . The oxidized form of lowdensity lipoprotein-Cholesterol (ox-LDL), which acts via binding to scavenger receptors (SR) and accumulates in cytoplasm, has been reported to play a causative role in the genesis and progression of AS [6] . Moreover, it is well established that receptor-mediated cholesterol efflux and reverse cholesterol transplant are major mechanisms for the removal of cellular cholesterol, and CE hydrolysis represents the ratelimiting step [7] . Therefore, understanding the biological mechanisms that regulate macrophage CE hydrolysis and promote cholesterol efflux is critical to protect macrophages from forming foam cells and attenuate the progression of AS.
SIRT6 is a nucleus-associated deacetylase that belongs to the Sirtuin protein family [8] . It is best known as a NAD+-dependent deacetylase on lysine 9 (H3K9) and lysine 56 (H3K56) of histone H3 [9, 10] , through which it regulates gene expression, telomere maintenance, and genomic stability [11] [12] [13] [14] . The role of SIRT6 in modulating lipid metabolism is wellcharacterized. A liver-specific SIRT6 knockout has been shown to cause fatty liver formation, and SIRT6 has been found to work together with FOXO3 to inhibit PCSK9 expression and regulate cholesterol homeostasis [15, 16] . Recently, the role of SIRT6 in cardiovascular diseases has drawn increasing attention. SIRT6 has been reported to help reduce myocardial hypertrophy by negatively regulating cardiac insulinlike growth factor (IGF)-AKT signaling [17] [18] [19] . Additionally, SIRT6 has been found to ameliorate endothelial dysfunction by interacting with the nuclear factorkappa b (NF-kb) subunits RelA and p65, and thereby inhibiting the pro-inflammatory NF-kb signaling pathway [20] [21] [22] . Importantly, lentivirus-mediated SIRT6 knockdown in ApoEÀ/À mice revealed that SIRT6 depletion led to larger lesion areas of the aorta and more vulnerable plaques [23] , underscoring the importance of SIRT6 in AS.
Autophagy is a highly conserved cellular process responsible for the degradation of long-lived proteins and dysfunctional organelles and for maintaining the turnover of cytoplasmic components in response to metabolic demands. It plays a pivotal role in human pathologies, such as cancer, aging, neurodegenerative disorders, and cardiovascular diseases [24] . 'Lipophagy,' a selective form of macroautophagy, has been proposed recently [25] . Accordingly, cytosolic LDs are sequestered by double-membrane vacuoles called autophagosomes and subsequently delivered to the lysosome for degradation by lysosomal acid lipase. This pathway is activated in lipid-loaded macrophages and contributes considerably to cholesterol efflux and CE hydrolysis in cytosolic LDs, while preventing cellular lipid accumulation and foam cell formation [26] . Moreover, pharmacological inhibition of autophagy by 3-methyladenine (3-MA) or genetic knockdown of the crucial autophagy gene ATG5 in macrophages markedly inhibit cholesterol efflux and augment foam cell formation [25] . Importantly, the recent finding that Wip1 phosphatasedeficient mice exhibit enhanced autophagy in macrophages, and consequently, are exempt from foam cell formation and AS, supports the vital function played by autophagy in macrophage cholesterol clearance [27] . Together, these studies suggest that autophagy plays a protective role in macrophage foam cell formation. As a result, molecules that regulate autophagy may represent effective therapeutic targets for the treatment of AS.
The role of SIRT6 in autophagy has been explored in recent years. Takasaka et al. showed that SIRT6 protected human bronchial epithelial cells from cigarette smoke-induced senescence by attenuating IGF-AKT signaling and consequent autophagy stimulation [28] . In neuronal models, SIRT6 was reported to aggravate oxidative stress induced by neural damage through an increase in autophagy and ROS production [29] . Additionally, autophagy induction by SIRT6 has been associated also with protecting cardiomyocytes from hypertrophy caused by isoproterenol treatment [30] . However, the connection between SIRT6 and autophagy in macrophages and its impact on the pathological development of AS have not been evaluated. Moreover, any possible underlying mechanism, other than attenuating IGF-AKT-mTOR signaling, has not been identified yet.
In this study, we observed that SIRT6 overexpression protected THP1 cells treated with oxidized lowdensity lipoprotein (ox-LDL) from forming foam cells, whereas SIRT6 knockdown aggravated foam cell formation. Furthermore, we proved that this effect was dependent on autophagy-induced lipophagy and cholesterol efflux. SIRT6 overexpression and miR-33 inhibition may serve as new potent tools for mitigating the effect of AS.
Results

SIRT6 and autophagy are inhibited in THP1 cells treated with ox-LDL
To examine the change in SIRT6 expression in macrophages under normal and atherosclerotic conditions, we first established a model of AS-associated macrophage foam cells. We achieved this by co-culturing differentiated human monocytic THP1 cells with 50 lgÁmL À1 ox-LDL for 24 h. Oil Red O (ORO) staining was performed to detect foam cell formation. As shown in Fig. 1A , cells treated with ox-LDL contained more LDs in the cytoplasm than untreated cells, indicating that a successful cell model was established. Interestingly, SIRT6 was observed to be significantly downregulated in cells treated with ox-LDL compared with control both in the presence or absence of Chloroquine (CQ), which inhibits autophagy flux by preventing the fusion of autophagosome and lysosome (Fig. 1B,D) . LC3B and ATG5, two well-known effectors of autophagosome formation, were also observed to be downregulated, and the protein level of SQSTM1/p62, a selective receptor of autophagy substrates, was increased in ox-LDL group with or without CQ treatment (Fig. 1B,D) , suggesting that autophagosome formation and substrate degradation were blocked in lipid-laden macrophages. To further confirm the effect of ox-LDL in macrophage autophagy, we performed fluorescence imaging of dualtagged mRFP-GFP-LC3 by confocal microscopy. In this system, LC3 was tagged with both GFP and mRFP. Together, these emit a yellow signal in pHneutral autophagosomes, but after fusion with lysosomes, the pH-sensitive GFP signal diminishes and only red mRFP signal can be detected. As shown in Fig. 1C , reduced GFP and mRFP dots as well as mRFP/GFP ratio demonstrated that autophagy flux was indeed impaired in macrophage foam cells induced by ox-LDL. In summary, we report that, compared to normal macrophages, foam cells have lower SIRT6 expression as well as impaired autophagy flux.
Overexpression of SIRT6 inhibits foam cell formation
To determine the role of SIRT6 in the pathogenesis of AS, we established cell lines overexpressing SIRT6 wild-type (LV-SIRT6), SIRT6 H133Y (LV-H133Y) whose HDAC activity was absent and SIRT6 knocked down (LV-shSIRT6) by means of recombinant lentivirus, respectively ( Fig. 2A,B) . Based on western blot and quantitative real-time PCR (qRT-PCR) results, both shRNA types proved to be efficient and so we chose shRNA-2 for all subsequent experiments ( Fig. 2A,B) . We conducted ORO staining and observed an obvious decrease in foam cell formation in the LV-SIRT6 group but not LV-H133Y group compared to the LV-Vector control (Fig. 2C) , suggesting that SIRT6 could relive macrophage foam cell formation and this efficacy depended on its HDAC activity. However, no obvious change was detected in foam cell formation between LV-shScram and LV-shSIRT6 (Fig. 2C ). This observation was further supported by cholesterol assays, which showed a 32% decrease in total cholesterol content and a 43% decrease in CE in the LV-SIRT6 group but not LV-H133Y group relative to the LV-Vector cells (Fig. 2C ). These data collectively show that SIRT6 relies on its HDAC activity Data are from one experiment as shown; they are representative of three independent experiments (means AE SEM). *P < 0.05, **P < 0.01, and ***P < 0.001 vs. no ox-LDL treatment control group; #P < 0.05, ##P < 0.01 vs. corresponding controls.
to protect against AS pathogenesis by decreasing foam cell formation.
SIRT6 enhances autophagy in THP1 cells treated with ox-LDL
Given the observed pattern of SIRT6 expression and autophagy flux in THP1 cells, we hypothesized that SIRT6 might be involved in macrophage autophagy. Therefore, we used western blot and qRT-PCR to assess autophagy flux in each cell group. We observed no obvious differences in the expression of specific autophagy markers among those five cell groups cultured in normal medium. However, after incubation with ox-LDL for 24 h, expression of numerous autophagy-related molecules was altered. The expression of lipidated LC3B protein (LC3B-II) and ATG5 as well as mRNA levels of LC3B and ATG5 were higher in the LV-SIRT6 than those in the LV-Vector and LV-H133Y groups, and they were lower in LV-shSIRT6-treated cells than in those of the LV-shScram group (Fig. 3A ,B). The opposite could be observed of SQSTM1/p62 protein levels, whereas no obvious differences were detected in terms of mRNA expression (Fig. 3A,B) . Besides, protein levels of LC3B and SQSTM1/p62 in cells treated with CQ was much higher than those in control cells and the expression pattern of autophagy effectors were similar with the control (Fig. 3A ). Other autophagy-related genes ULK1 and Beclin1 also presented a higher mRNA expression in the ox-LDL-treated LV-SIRT6 than those in the LV-Vector and LV-H133Y groups (Fig. 3B ). These collectively suggest that autophagy initiation and autophagy flux could be enhanced after SIRT6 WT overexpression in a lipid-laden condition.
Given that the change in autophagy was more prominent in an ox-LDL environment, in the following experiments we treated all groups with ox-LDL for 24 h. Fluorescent imaging of dual-tagged mRFP-GFP-LC3 was performed by confocal microscopy and LV-SIRT6 cells showed a greater number of yellow autophagosomes and red autophagolysosomes as well as a larger ratio of mRFP/GFP dots than LV-Vector and LV-H133Y cells did (Fig. 3C) , further confirming that SIRT6 WT overexpression induced autophagy flux in macrophages. To observe the autophagic vacuoles more directly, we employed transmission electron microscopy (TEM) and as shown in Fig. 3D , LV-SIRT6 cells formed more autophagosomes than LVVector and LV-H133Y cells did. To sum up, these data indicate that SIRT6 plays a pro-autophagic role through its HDAC activity during macrophage foam cell formation.
SIRT6 reduces foam cell formation in an autophagy-dependent pathway
To assess the relationship between elevated autophagy flux and reduced number of foam cells in the LV-SIRT6 group, we blocked autophagy by knocking down ATG5 with a specific siRNA (Fig. 4A) . The autophagy agonist rapamycin and inhibitor 3-MA were used as positive and negative controls, respectively, to evaluate the impact of autophagy on foam cell formation. As shown in Fig. 4B ,C, ATG5 knockdown effectively inhibited the initiation of autophagy, as seen by the downregulation of LC3B and accumulation of SQSTM1/p62. The effect of rapamycin and 3-MA on autophagy was confirmed by western blot (Fig. 4B,C) . As it was observed that rapamycin largely reduced lipid accumulation in THP1 cells while 3-MA had the opposite effect (Fig. 4D ), we examined whether autophagy was indispensable for SIRT6 to reduce foam cell formation. Inhibition of autophagy dramatically impaired the protective effect of SIRT6 in foam cell formation, as evidenced by increased lipid accumulation in LV-SIRT6 cells treated with ATG5-siRNA after ORO staining (Fig. 4D,E) . In summary, SIRT6 protects THP1 cells from foam cell formation by stimulating autophagy flux under ox-LDL conditions; blocking autophagy can abolish the efficacy of SIRT6.
SIRT6 overexpression promotes cholesterol efflux in THP1 cells and decreases the expression of miR-33
Given that autophagy had been reported to promote CE hydrolysis and cholesterol efflux [26] , we evaluated whether SIRT6 overexpression had a similar effect. Cholesterol efflux results showed that the LV-SIRT6 group had a higher level of cholesterol efflux to high-density lipoprotein (HDL) than the LV-Vector and LV-H133Y groups (Fig. 5A ). The levels of ABCA1 and ABCG1, which encode two transmembrane proteins that belong to the cholesterol reverse transporter family, increased in the LV-SIRT6 group compared to LV-Vector and LV-Vector cells, and decreased in the LV-shSIRT6 group relative to the LV-shScram group (Fig. 5B) . Furthermore, we examined mRNA expression of miR-33, a well-known negative regulator of ABCA1 and ABCG1, and demonstrated that miR-33, as well as its host gene SREBF2, were downregulated in the LV-SIRT6 group compared to the LV-Vector and LV-H133Y controls (Fig. 5B) . Given that miR-33 had been reported to block autophagy flux in Mycobacterium tuberculosis (Mtb)-infected macrophages [31] , we checked whether miR-33 could interfere with autophagy in ox-LDL-treated macrophages. We transfected differentiated THP1 cells with plasmids bearing miR-33 mimic or anti-miR-33, and observed that macrophage autophagy was inhibited in the miR-33 overexpression group relative to the control, as evidenced by the decreased expression of LC3B, ATG5, LAMP1 and the elevated level of p62 (Fig. 5C,D) . Moreover, we checked the miR-33 levels in ATG5 knockdown and control cells, and did not find obvious differences between the two (Fig. 5E ), indicating Representative TEM images of autophagosomes (arrow) and their quantitation in each cell group treated with ox-LDL. Data show means AE SEM of three independent experiments. Scale bars, 10 lm (C) and 500 nm (D). *P < 0.05, **P < 0.01, and ***P < 0.001 vs. corresponding vector controls. ##P < 0.01, and ###P < 0.001 vs. no CQ treatment controls.
that miR-33 acted upstream of ATG5. Taken together, these data indicate that SIRT6 overexpression reduces the level of miR-33, while promoting cholesterol efflux and inducing autophagy flux in lipid-laden macrophages.
miR-33 is a target of SIRT6 involved in promoting autophagy flux in macrophages and preventing foam cell formation
To evaluate the role of miR-33 in SIRT6-mediated autophagy in macrophages, we transfected differentiated THP1 cells from the LV-Vector and LV-SIRT6 groups with miR-33-bearing plasmids. As shown in Fig. 6A , the higher levels of LC3B, ATG5, and LAMP1 obtained by overexpressing SIRT6 were reduced in cells transfected with miR-33 compared with those bearing the control plasmid. This was confirmed by dual-tagged-LC3 detection (Fig. 6B ) and ORO staining (Fig. 6C ), whereby autophagy flux was diminished and many more foam cells were present in the miR-33 overexpression group compared with the control. This suggested that SIRT6-dependent autophagy flux in lipid-laden macrophages was induced at least in part by suppressing miR-33. To sum up, SIRT6 overexpression lowers the level of miR-33, which not only increases autophagy flux but also upregulates ABCA1 and ABCG1 expression, concomitantly promoting cholesterol efflux and preventing macrophage foam cell formation (Fig. 7) .
Discussion
Atherosclerosis has been recognized as a major threat to diabetic patients [1] . The pathogenesis of AS is complicated by the contribution of several types of cells. The formation of macrophage foam cells is considered the initiation step in this pathological process. Interventions focused on this aspect of AS could effectively prevent the onset or progression of the disease [2, 3] . Our data show that by overexpressing SIRT6 WT but not SIRT6 H133Y, autophagy flux in THP1 cells was enhanced under ox-LDL conditions and foam cell formation was relieved. This effect was, at least in part, due to the repression of miR-33 and upregulation of ABCA1 and ABCG1. We found that SIRT6, as well as autophagy effectors (LC3B-II, ATG5) and LAMP1, were downregulated in macrophage foam cells formed in ox-LDL-treated THP1 cells. LAMP1 is a glycoprotein that resides primarily across lysosomal membranes which is in part responsible for maintaining lysosomal integrity, pH, and catabolism and is widely considered as the marker of lysosomal biogenesis [32, 33] . Enhanced lysosomal biogenesis is associated with elevated autophagy flux [34] . In a stably overexpressing SIRT6 WT cell line (LV-SIRT6) but not the mutant group (LV-H133Y), we observed a clear induction of autophagy flux after treatment with ox-LDL, as determined by both laser scanning confocal microscopy (LSCM) and TEM. Meanwhile, more lysosomes were formed in the LV-SIRT6 cells compared to LV-Vector and LV-H133Y examined by Lysotracker Red staining (data not shown). This autophagy-dependent pathway was further validated by the observation that silencing ATG5, an essential autophagy initiation gene, largely compromised the beneficial effect derived from overexpressing SIRT6. Cells overexpressing SIRT6 were characterized by elevated cholesterol efflux, upregulated ABCA1 and ABCG1, and downregulated miR-33. miR-33 has been reported to block autophagy flux and contribute to lipid accumulation in Mtb-infected macrophages [31] . Our findings whereby miR-33 overexpression facilitated autophagy flux reduction in macrophages treated with ox-LDL and aggravated foam cell formation were inconsistent with that report. Importantly, by overexpressing miR-33 in LV-SIRT6 cells, the enhanced autophagy flux was abolished and more foam cells were subsequently formed. This result supports the hypothesis that SIRT6 participates in ameliorating AS by elevating the expression of ABCA1 and ABCG1, and promoting autophagy flux and lipid hydrolysis via inhibition of miR-33 expression. Our identification of SIRT6 as a regulator of autophagy in THP1 cells provides a fresh example of the multiple targets and functions it is involved in, especially in the context of cardiovascular diseases. Although, the favorable effects of SIRT6 in lipid metabolism, such as reducing fatty liver and triglyceride synthesis, and promoting b-oxidation in hepatocytes, were already well-known [8] ; research on the role of SIRT6 in cardiovascular diseases and AS has only recently received more attention. SIRT6 was reported to be crucial in protecting the aorta from maldevelopment and AS [17] [18] [19] [20] [21] [22] [23] ; however, its involvement in macrophage function and the underlying mechanisms have not been studied yet. Given that SIRT6 is involved in modulating autophagy in several cell types [28] [29] [30] , it is consistent that it also regulates autophagy in macrophages. Interestingly, our data showed that SIRT6 induced autophagy flux more evidently after ox-LDL treatment. The reason for this phenomenon is complicated and we assume that autophagy is a mechanism for self-protection in cells when confronting challenges, and the observation of autophagy will be more dominant under extra stresses such as ox-LDL. Besides, many researches into selective lipophagy has been held back by a lack of reliable methods for inducing it, so the ox-LDL-induced autophagy enhancement by SIRT6 overexpression in our study provided a useful strategy for selectively inducing lipophagy. As reported, miR-33 has a prominent role in mediating cholesterol homeostasis and has atherosclerotic-promoting properties [35] [36] [37] . Moreover, Ouimet et al., have recently reported that miR-33 interferes with the autophagy pathway in Mtb-infected macrophages, inhibiting FOXO3 and AMPK pathways [31] .
But it remains to be seen whether miR-33 plays a role (means AE SEM). ##P < 0.01 vs. no ox-LDL treatment control; *P < 0.05, **P < 0.01, and ***P < 0.001 vs. corresponding controls.
in macrophage autophagy under other stress conditions and to what biological outcome this may lead. Our data demonstrate that under ox-LDL treatment, SIRT6 overexpression blocks macrophage foam cell formation through a previously unknown mechanism that relies on inducing macrophage autophagy flux in a miR-33-dependent manner. Although our study did not pinpoint the precise target of SIRT6 in this pathway, it unveiled the important role played by SIRT6 and its HDAC activity in cardiovascular diseases and may provide a novel target for future treatment. In subsequent studies, we aim to broaden our understanding of SIRT6 by collecting in vivo data from experimental animals such as genomic knockout mice. 
Materials and methods
Reagents and antibodies
Reagents and antibodies used in this study was listed in Tables 1 and 2 , respectively.
Cell culture and foam cell induction
The THP1 cell line was obtained from the China Cell Culture Center (Shanghai, China). Cells were maintained in RPMI 1640 medium containing 10% FBS and 1% penicillin-streptomycin at 37°C in a humidified atmosphere with 5% CO 2 . Cells were cocultured with 100 nM phorbol-12-myristate acetate (PMA) for 72 h to induce differentiation into macrophages and were subsequently incubated with 50 lgÁmL 
Immunoblot analysis
Cells were washed two to three times with ice-cold phosphate-buffered saline (PBS) and lysed in RIPA buffer containing protease and phosphatase inhibitors (Roche Diagnostics, Mannheim, Germany). Total protein samples (25-30 lg per well) were loaded onto 8% or 10% SDS-polyacrylamide gels for separation and transferred to polyvinylidene fluoride (PVDF) membranes (EMD Millipore, Billerica, MA, USA) at 300 mA for 1 h. For LC3B, 15% gels were used and proteins were transferred to 0.2-lm PVDF membranes. Membranes were blocked with 5% bovine serum albumin for 1 h before incubation with the appropriate antibodies at 4°C overnight. Protein bands were detected using an enhanced horseradish peroxidase (HRP)-based chemiluminescence detection system (HRP-conjugated secondary antibodies; DAKO Corporation, Carpinteria, CA, USA; Immobilon western chemiluminescent HRP substrate; EMD Millipore, Billerica, MA, USA) and analyzed using IM-AGE J software (NIH, Bethesda, MD, USA).
RNA isolation and qRT-PCR
Total RNA from THP1 cells (LV-Vector, LV-SIRT6, LVshScram, and LV-shSIRT6) was extracted using TRIzol reagent. cDNA was synthesized using the PrimeScript RT reagent Kit with gDNA Eraser (TaKaRa, Tokyo, Japan) according to the manufacturer's protocol. For qRT-PCR, we used SYBR Premix Ex Taq (TaKaRa) and results were normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Primer sequences are listed in Table 3 .
miR-33 and anti-miR-33 transfections
Differentiated THP1 macrophages were transfected with 120 nM hsa-miR-33 or anti-miR-33 (both Hanbio Biotechnology, Shanghai, China) via Fugene HD transfection according to the manufacturer's protocol. Cells were transfected with equal amounts of ctrl-mimic or ctrl-anti-miR-33, which were used as nonspecific controls.
miRNA quantitation microRNA was isolated using the miRcute miRNA isolation kit (Tiangen Biotech, Beijing, China). miRNA FirstStrand cDNA Synthesis Kit (Tiangen Biotech) was used for the reverse transcription reaction, according to the manufacturer's instructions. For relative quantitation, miRcute miRNA qPCR Detection Kit (SYBR Green) (Tiangen Biotech) was used and miRNA levels were normalized to hsa-U6. The miRNA primers used are listed in Table 4 .
Stable cell line construction
The LV-SIRT6 plasmid was generously provided by Juan Cai (Shanghai Jiaotong University) and LV-SIRT6 H133Y plasmid was from Cong Yu (Zhejiang University school of medicine). For RNA interference, two pairs of short hairpin sequences against SIRT6 were designed: sh 
Autophagy flux analysis
To analyze autophagy flux in each cell group, we infected LV-SIRT6, LV-H133Y and LV-shSIRT6, as well as the corresponding controls, with dual-tagged LC3 (mRFP-GFP-LC3) adenovirus (Hanbio Biotechnology) according to the manufacturer's instructions. Briefly, 80MOI adenovirus was added to the medium when cells reached 50% confluence. Cells were incubated for 2 h at 37°C before being transferred to fresh complete medium in which they were further cultivated for 24-48 h. Fluorescence Images were captured by LSCM Nikon, Tokyo, Japan). Three regions of interest were randomly selected, GFP and mRFP dots/cell and the ratio of mRFP/GFP were used for quantitation of autophagy flux, and five cells were counted in each group.
TEM
After exposure to ox-LDL for 24 h, cells were harvested and fixed with 2.5% glutaraldehyde for 2-3 h at 4°C. Then, cells were washed three times with 0.1 M phosphate buffer and fixed in 1% aqueous osmium at 4°C for 1-2 h, dehydrated with increasing concentrations of acetone (30, 50, 70, 80, 90 , and 100%), and embedded in araldite. The ultrathin sections were produced with a microtome (Leica, Jena, Germany) and stained with 3% aqueous uranyl acetate and lead citrate. Autophagosomes are defined as double layer membrane structure containing cytoplasmic contents (mitochondria, lipid, damaged organelles, etc.) waiting to be degraded. Results were observed in a transmission electron microscope (Hitachi H-7000FA, Tokyo, Japan) and demonstrated as the number of autophagosomes per cell. Images of five view fields were taken for data analysis.
ORO staining and cholesterol measurement
Macrophage lipid accumulation and foam cell formation were examined by cholesterol measurements and ORO staining, respectively. THP1 cells were cultured in a 12-well plate and differentiation into macrophages was induced by applying PMA for 72 h. Cells were treated with 50 lgÁmL
À1
human ox-LDL for 24 h to induce foam cell formation when required. Cells were fixed in 4% paraformaldehyde for Table 4 . Sequences of miRNA primers used in this study.
Gene Primer (5 0 -3 0 )
hsa-miR-33a-5p GUGCAUUGUAGUUGCAUUGCA hsa-miR-33a-3p CAAUGUUUCCACAGUGCAUCAC hsa-miR-33b-5p GUGCAUUGCUGUUGCAUUGC hsa-miR-33b-3p CAGUGCCUCGGCAGUGCAGCCC 15 min, washed in PBS three times, stained with 0.5% ORO for 15 min at room temperature (20-25°C), and washed with 60% isopropanol before being observed under the microscope. For ORO quantitation, isopropanol was added to each sample, which was then shaken at room temperature for 10 min. Absorbance was read at 520 nm using a microplate reader. Cholesterol content was measured by an Amplex Red cholesterol assay kit (Invitrogen, Eugene, OR, USA) following the manufacturer's instruction. Total and free cholesterol content were measured using a fluorescence microplate reader and CE levels were calculated by normalization to protein levels for each sample.
Cholesterol efflux assay
The effect of SIRT6 on cholesterol efflux in THP1 cells was examined with the Cholesterol efflux assay kit (Sigma-Aldrich) according to the manufacturer's instructions. Briefly, THP1 cells were incubated in a 96-well plate and induced to differentiate with PMA. The Reaction Mix (100 lL) was added to each well and the plate was incubated at 37°C for 16 h before human HDL was added to each well as a cholesterol acceptor. Incubation continued for another 4-6 h. The supernatant was transferred to a fresh 96-well plate and fluorescence was measured using a multiwell plate reader (Fm, kex = 482/kem = 515 nm). The cell monolayer was lysed by adding 100 lL per well Cell Lysis Buffer and then shaking the plate for 30 min at room temperature. The cell lysate was transferred with medium to a fresh 96-well plate and the contents were mixed by pipetting before measuring fluorescence (Fc, kex = 482/kem = 515 nm). The outcome was calculated by dividing the Fm and Fc in each group (C = 100%*Fm/Fc). All samples were run in duplicate.
Statistics
Data are presented as mean AE standard error of the mean (SEM) and the statistical significance of the differences was evaluated by Student's t-test. For multiple group comparisons, analysis of variance (ANOVA) tests were conducted. Significance was considered at the level of P ≤ 0.05.
